Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR-CMV
NCT07235683Phase 4Recruiting
- Sponsor
- University Health Network
- Start
- Dec 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of letermovir in cytomegalovirus infection (CMV), sponsored by University Health Network. Started Dec 2025; status: recruiting.
02
Drugs
letermovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT07235683.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07235683.